BDSX Biodesix Inc

Price (delayed)

$1.64

Market cap

$188.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$237.77M

Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue ...

Highlights
BDSX's EPS has soared by 59% year-on-year and by 16% since the previous quarter
The company's gross profit has surged by 57% YoY and by 16% QoQ
BDSX's debt has soared by 57% YoY
Biodesix's quick ratio has plunged by 50% YoY and by 33% from the previous quarter

Key stats

What are the main financial stats of BDSX
Market
Shares outstanding
114.69M
Market cap
$188.08M
Enterprise value
$237.77M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
2.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.33
Earnings
Revenue
$54.85M
EBIT
-$37.38M
EBITDA
-$32.1M
Free cash flow
-$46.12M
Per share
EPS
-$0.54
Free cash flow per share
-$0.47
Book value per share
-$0.06
Revenue per share
$0.56
TBVPS
$0.67
Balance sheet
Total assets
$87.2M
Total liabilities
$92.7M
Debt
$61.18M
Equity
-$5.5M
Working capital
-$2.75M
Liquidity
Debt to equity
-11.12
Current ratio
0.91
Quick ratio
0.68
Net debt/EBITDA
-1.55
Margins
EBITDA margin
-58.5%
Gross margin
76.3%
Net margin
-85.8%
Operating margin
-65.6%
Efficiency
Return on assets
-53.7%
Return on equity
N/A
Return on invested capital
-54.3%
Return on capital employed
-66.8%
Return on sales
-68.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BDSX stock price

How has the Biodesix stock price performed over time
Intraday
0%
1 week
-7.34%
1 month
-4.09%
1 year
40.17%
YTD
-10.87%
QTD
7.19%

Financial performance

How have Biodesix's revenue and profit performed over time
Revenue
$54.85M
Gross profit
$41.83M
Operating income
-$35.99M
Net income
-$47.06M
Gross margin
76.3%
Net margin
-85.8%
The company's gross profit has surged by 57% YoY and by 16% QoQ
BDSX's net margin is up by 49% YoY and by 19% QoQ
The operating margin has increased by 49% year-on-year and by 22% since the previous quarter
Biodesix's revenue has increased by 35% YoY and by 12% QoQ

Growth

What is Biodesix's growth rate over time

Valuation

What is Biodesix stock price valuation
P/E
N/A
P/B
N/A
P/S
2.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.33
BDSX's EPS has soared by 59% year-on-year and by 16% since the previous quarter
Biodesix's revenue has increased by 35% YoY and by 12% QoQ
The price to sales (P/S) is 8% higher than the last 4 quarters average of 2.7

Efficiency

How efficient is Biodesix business performance
BDSX's ROIC has soared by 75% YoY and by 24% QoQ
BDSX's ROS has soared by 53% year-on-year and by 21% since the previous quarter
BDSX's return on assets is up by 39% year-on-year and by 11% since the previous quarter

Dividends

What is BDSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BDSX.

Financial health

How did Biodesix financials performed over time
The company's total assets is 6% lower than its total liabilities
Biodesix's quick ratio has plunged by 50% YoY and by 33% from the previous quarter
The company's current ratio fell by 42% YoY and by 24% QoQ
The debt to equity has dropped by 184% since the previous quarter
BDSX's debt has soared by 57% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.